News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
299,904 Results
Type
Article (16729)
Company Profile (122)
Press Release (283045)
Multimedia
Podcasts (68)
Webinars (14)
Section
Business (93517)
Career Advice (493)
Deals (16053)
Drug Delivery (78)
Drug Development (40662)
Employer Resources (59)
FDA (7016)
Job Trends (6864)
News (161026)
Policy (15271)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (693)
Accelerated approval (15)
Adcomms (9)
Allergies (75)
Alliances (25076)
ALS (87)
Alzheimer's disease (608)
Antibody-drug conjugate (ADC) (109)
Approvals (7233)
Artificial intelligence (217)
Autoimmune disease (50)
Automation (14)
Bankruptcy (152)
Best Places to Work (5017)
BIOSECURE Act (9)
Biosimilars (119)
Biotechnology (51)
Bladder cancer (50)
Brain cancer (37)
Breast cancer (206)
Cancer (1642)
Cardiovascular disease (181)
Career advice (444)
Career pathing (14)
CAR-T (78)
CDC (7)
Cell therapy (235)
Cervical cancer (9)
Clinical research (35341)
Collaboration (816)
Compensation (356)
Complete response letters (36)
COVID-19 (929)
CRISPR (55)
C-suite (461)
Cystic fibrosis (74)
Data (2273)
Denatured (18)
Depression (53)
Diabetes (199)
Diagnostics (1581)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (15)
Drug discovery (129)
Drug pricing (122)
Drug shortages (14)
Duchenne muscular dystrophy (113)
Earnings (34919)
Editorial (22)
Employer branding (7)
Employer resources (52)
Events (43364)
Executive appointments (564)
FDA (8293)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (5)
Funding (543)
Gene editing (107)
Generative AI (18)
Gene therapy (243)
GLP-1 (474)
Government (1670)
Grass and pollen (4)
Guidances (172)
Healthcare (4692)
HIV (30)
Huntington's disease (14)
IgA nephropathy (42)
Immunology and inflammation (74)
Immuno-oncology (14)
Indications (58)
Infectious disease (1013)
Inflammatory bowel disease (84)
Inflation Reduction Act (8)
Influenza (27)
Intellectual property (121)
Interviews (65)
IPO (6334)
IRA (37)
Job creations (2104)
Job search strategy (396)
JPM (30)
Kidney cancer (10)
Labor market (31)
Layoffs (216)
Leadership (9)
Legal (3597)
Liver cancer (29)
Longevity (8)
Lung cancer (238)
Lymphoma (158)
Machine learning (15)
Management (19)
Manufacturing (432)
MASH (79)
Medical device (1566)
Medtech (1574)
Mergers & acquisitions (10188)
Metabolic disorders (543)
Multiple sclerosis (51)
NASH (14)
Neurodegenerative disease (101)
Neuropsychiatric disorders (38)
Neuroscience (1116)
Neurotech (1)
NextGen: Class of 2026 (2012)
Non-profit (1786)
Now hiring (18)
Obesity (255)
Opinion (167)
Ovarian cancer (47)
Pain (111)
Pancreatic cancer (59)
Parkinson's disease (107)
Partnered (13)
Patents (238)
Patient recruitment (147)
Peanut (19)
People (31460)
Pharmaceutical (65)
Pharmacy benefit managers (18)
Phase 1 (9462)
Phase 2 (15059)
Phase 3 (13235)
Pipeline (2133)
Policy (148)
Postmarket research (1497)
Preclinical (3843)
Press Release (27)
Prostate cancer (97)
Psychedelics (20)
Radiopharmaceuticals (135)
Rare diseases (428)
Real estate (2772)
Recruiting (22)
Regulatory (11964)
Reports (16)
Research institute (985)
Resumes & cover letters (58)
Rett syndrome (7)
RNA editing (9)
RSV (25)
Schizophrenia (73)
Series A (91)
Series B (62)
Service/supplier (2)
Sickle cell disease (61)
Special edition (11)
Spinal muscular atrophy (112)
Sponsored (12)
Startups (1777)
State (2)
Stomach cancer (6)
Supply chain (52)
Tariffs (69)
The Weekly (48)
Vaccines (282)
Venture capital (35)
Weight loss (157)
Women's health (29)
Worklife (4)
Date
Last 7 days (204)
Last 30 days (751)
Last 365 days (11849)
2026 (1057)
2025 (12188)
2024 (14266)
2023 (16131)
2022 (21906)
2021 (22695)
2020 (21387)
2019 (17188)
2018 (13408)
2017 (15061)
2016 (14456)
2015 (16924)
2014 (13373)
2013 (11314)
2012 (12005)
2011 (12554)
2010 (11462)
Location
Africa (358)
Alabama (19)
Alaska (3)
Arizona (84)
Arkansas (3)
Asia (22054)
Australia (2973)
California (3770)
Canada (1606)
China (584)
Colorado (153)
Connecticut (151)
Delaware (151)
Europe (43977)
Florida (642)
Georgia (73)
Hawaii (1)
Idaho (17)
Illinois (376)
India (44)
Indiana (243)
Iowa (3)
Japan (259)
Kansas (84)
Kentucky (22)
Louisiana (5)
Maine (3)
Maryland (515)
Massachusetts (2957)
Michigan (49)
Minnesota (181)
Mississippi (1)
Missouri (33)
Montana (9)
Nebraska (7)
Nevada (23)
New Hampshire (9)
New Jersey (1557)
New Mexico (7)
New York (1099)
North Carolina (736)
North Dakota (4)
Northern California (1803)
Ohio (123)
Oklahoma (5)
Oregon (19)
Pennsylvania (833)
Puerto Rico (12)
Rhode Island (19)
South America (539)
South Carolina (11)
Southern California (1572)
Tennessee (56)
Texas (549)
United States (14638)
Utah (63)
Virginia (173)
Washington D.C. (44)
Washington State (257)
West Virginia (1)
Wisconsin (42)
Wyoming (1)
299,904 Results for "cure pharmaceutical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biocomposites gains MDR certification for STIMULAN® Rapid Cure and STIMULAN® Kit
February 5, 2026
·
2 min read
Infectious disease
GSK, Ionis Achieve Functional Cure in Hepatitis B Studies, Clearing Path for FDA Run
Though specific data for bepirovirsen remain under wraps, GSK plans to file for approval in the first quarter of 2026.
January 7, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform
January 5, 2026
·
5 min read
Infectious disease
Biopharma Targets an HIV Cure as NIH Funding Cuts Threaten To Derail Progress
As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are targeting the next goalpost: a cure.
May 12, 2025
·
7 min read
·
Heather McKenzie
Press Releases
Curebound Awards $8.5 Million for 23 Cancer Research Studies, Including $1 Million Cure Prize
December 11, 2025
·
7 min read
Press Releases
Cibus Therapeutics Announces Strategic Partnership with Mission: Cure and Greenstone Biosciences to Accelerate Development of CBT-101, a Novel Therapy for Chronic Pancreatitis
December 19, 2025
·
1 min read
IN PARTNERSHIP WITH ECLIPSEBIO
Webinar: The Future of mRNA Medicine: How Advanced Data Empowers Cures
This discussion focuses on how sequencing-based insights can power AI-driven design and data-driven validation, helping to develop safe and effective drugs for treating and preventing disease.
October 22, 2025
·
1 min read
·
BioSpace Insights
Opinion
Pharma Is Sitting on Hidden Cures. Find Your “Freda” To Unlock Them
Had Pfizer’s Freda Lewis-Hall not stepped in, SpringWorks’ rare disease treatment may never have reached patients. Pharmas can act now to help find the next Gomekli.
November 4, 2025
·
4 min read
·
Annette Bakker
Opinion
Opinion: Antagonism to mRNA Technology Is Killing Our Best Shot at a Cure for Cancer
The recent announcement of RFK Jr.’s termination of mRNA vaccine contracts is the latest effort to undermine this promising technology at the federal level. Pharmaceutical companies and private investors must fill the gap and ensure that research into this critical resource continues.
August 11, 2025
·
6 min read
·
Jonathan Kagan, PhD
Press Releases
Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson
November 19, 2025
·
6 min read
1 of 29,991
Next
